Molina Healthcare (MOH) fundamentals: P/E, valuation, undervalued?
Molina Healthcare · Health Care · ref. ETF XLV · price $209.5
In short — Molina Healthcare trades at 2327.8× earnings (P/E), 21.5× forward, with a net margin of -0.0 % and revenue growth of -6 %. Read: Very high P/E (P/E 2328 (well above average)).
Is Molina Healthcare stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$209.5+7.5% over range
Oct 14, 25low $122.65 · high $242.88Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 10 analysts
Valuation : Very high P/E — P/E 2328 (well above average)
Valuation
2327.8
P/E (price/earnings)
21.5
Forward P/E
—
PEG
2.6
Price/book (P/B)
$10.9B
Market cap
0.09
EPS
Profitability & growth
-0.0 %
Net margin
-6 %
Revenue growth
-75 %
Earnings growth
$4.0B
Total debt
Molina Healthcare income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $32.0B | $792M | 2.5 % |
| 2023 | $34.1B | $1.1B | 3.2 % |
| 2024 | $40.6B | $1.2B | 2.9 % |
| 2025 | $45.4B | $472M | 1.0 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Molina Healthcare's P/E and is the stock undervalued? What's a good P/E?
Molina Healthcare's P/E is 2327.8 (forward 21.5). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Very high P/E".
Is Molina Healthcare profitable?
Molina Healthcare has a net margin of -0.0 % (EPS 0.09). The company is not (yet) profitable.
Is MOH stock expensive?
Our read: "Very high P/E" — P/E 2328 (well above average). Cross-check with growth and sector.
💬 A question about Molina Healthcare? The JPI assistant answers using our backtest data.
Keep exploring Molina Healthcare